Eric D Wieben

Title: The Innovative Mind of Eric D. Wieben: Advancements in Sulfotransferase Research

Introduction: Eric D. Wieben, based in Rochester, MN, is a prolific inventor with a remarkable portfolio of 23 patents. His groundbreaking work primarily revolves around the field of molecular genetics, specifically concerning sulfotransferases and their implications in cancer predisposition.

Latest Patents: Among Wieben's latest patents, he has developed isolated sulfotransferase nucleic acid molecules that feature nucleotide sequence variants along with flanking nucleotides. These innovations include sulfotransferase allozymes, contributing significant insights into genetic variations. Furthermore, his patents describe methods for identifying whether a mammal is predisposed to cancer, thus positing valuable techniques for early detection and intervention.

Career Highlights: Eric D. Wieben is affiliated with the Mayo Foundation for Medical Education and Research, where he has contributed extensively to advancing medical research through innovative inventions. His work aligns with the foundation's mission of enhancing patient care through research and education, establishing him as a key figure in the medical research community.

Collaborations: Collaborating closely with other esteemed researchers, Wieben works alongside Richard M. Weinshilboum and Bianca A. Thomae. Together, they form a dynamic team that drives forward the frontiers of research in pharmacogenomics and cancer predisposition, demonstrating the power of teamwork in scientific discovery.

Conclusion: Eric D. Wieben stands out as an influential inventor whose patents significantly advance our understanding of sulfotransferases and their roles in genetic predispositions to cancer. His ongoing contributions to the Mayo Foundation for Medical Education and Research not only highlight his innovative spirit but also emphasize the importance of collaboration in the pursuit of medical breakthroughs.